Nitrofurantoin for Uncomplicated Urinary Tract Infections
Nitrofurantoin monohydrate/macrocrystals (100 mg twice daily for 5 days) is the recommended first-line treatment for uncomplicated urinary tract infections due to its minimal resistance rates, limited collateral damage to gut flora, and excellent efficacy. 1
First-Line Treatment Options
Nitrofurantoin dosing:
Efficacy evidence:
- Significantly more effective than placebo in achieving both bacteriological cure and symptomatic relief within 3 days (NNT = 1.6) 3
- Maintains good activity against common uropathogens including Escherichia coli, Staphylococcus saprophyticus, and Enterococcus species despite 60+ years of use 4
- Particularly valuable in the era of increasing resistance to other antibiotics 5
Alternative First-Line Options
Fosfomycin trometamol:
Trimethoprim-sulfamethoxazole:
Special Considerations and Contraindications
Contraindications for nitrofurantoin:
- Renal impairment of any degree
- Last trimester of pregnancy
- Known hypersensitivity 4
Monitoring:
Management of Treatment Failure
If symptoms don't resolve by end of treatment or recur within 2 weeks:
- Perform urine culture with antimicrobial susceptibility testing
- Assume the infecting organism is resistant to the original agent
- Retreat with a 7-day regimen using a different antimicrobial agent
- Assess clinical response within 48-72 hours 2
Multidrug-Resistant Organisms
- For uncomplicated UTIs due to vancomycin-resistant enterococci (VRE):
Long-Term Prophylaxis
For recurrent UTIs (≥3 UTIs/year or ≥2 UTIs in last 6 months):
- Macrocrystalline nitrofurantoin 50 mg at bedtime has shown efficacy and favorable safety profile for long-term (12 months) prophylaxis 6
- Consider non-antimicrobial approaches first (increased fluid intake, vaginal estrogen for postmenopausal women) 2
Practical Considerations
- Nitrofurantoin should be taken with food to improve absorption and reduce gastrointestinal side effects
- Advise patients that urine may turn dark yellow or brown
- Most common side effects with short-term use are nausea and headache
- Serious adverse events (pulmonary reactions, polyneuropathy) are primarily associated with long-term use 4
Nitrofurantoin has regained prominence in treatment guidelines due to increasing resistance to fluoroquinolones and trimethoprim-sulfamethoxazole, making it an excellent first choice for uncomplicated UTIs when not contraindicated 4, 5.